DuPont Decomposition

Why does MEDANTA earn its ROE?

Breaking down Return on Equity into profitability, efficiency, and leverage.

ROE = Net Margin × Asset Turnover × Equity Multiplier

14.1% = 12.6% × 0.75 × 1.49

Latest: FY2026

Profitability

Net Margin

12.6%

9.1% →12.6%

How much profit per ₹ of revenue

Efficiency

Asset Turnover

0.75x

0.69x →0.75x

Revenue per ₹ of assets

Leverage

Equity Multiplier

1.49x

1.95x →1.49x

Assets funded by equity vs debt

Trend Analysis

ROE improved by 1.9 pp over 5 years. Driven by net margin improving (9.1% → 12.6%), leverage falling (1.95x → 1.49x).

Historical Decomposition

Last 5 years

YearRevenuePATNet MarginAsset TOLeverageROE
FY20220Cr0Cr9.1%0.691.9512.1%
FY20230Cr0Cr12.2%0.651.7013.4%
FY20240Cr0Cr14.8%0.751.4816.5%
FY20250Cr0Cr13.0%0.771.4114.2%
FY20260Cr0Cr12.6%0.751.4914.1%

How to read DuPont

  • Rising ROE from margin = pricing power, operational improvement (good)
  • Rising ROE from turnover = better asset utilization (good)
  • Rising ROE from leverage = more debt, amplified risk (caution)
  • Falling ROE across all three = structural deterioration (red flag)

See DCF fair value for MEDANTA

Combine financial quality with intrinsic value.

See Fair Value →

DuPont decomposition from audited annual financials. Factual analysis, not investment advice.

MEDANTA DuPont Analysis — ROE 14.1% | YieldIQ